{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T01:22:06Z","timestamp":1790126526229,"version":"4.0.1"},"reference-count":43,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2005,3,1]],"date-time":"2005-03-01T00:00:00Z","timestamp":1109635200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,3,1]],"date-time":"2005-03-01T00:00:00Z","timestamp":1109635200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Free Radical Biology and Medicine"],"published-print":{"date-parts":[[2005,3]]},"DOI":"10.1016\/j.freeradbiomed.2004.10.024","type":"journal-article","created":{"date-parts":[[2004,12,16]],"date-time":"2004-12-16T08:07:31Z","timestamp":1103184451000},"page":"711-718","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":141,"title":["Biomarkers of oxidative stress study"],"prefix":"10.1016","volume":"38","author":[{"given":"M.B.","family":"Kadiiska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.C.","family":"Gladen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.D.","family":"Baird","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.B.","family":"Graham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.E.","family":"Parker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.N.","family":"Ames","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Basu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.A.","family":"FitzGerald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.A.","family":"Lawson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.J.","family":"Marnett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.D.","family":"Morrow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.M.","family":"Murray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Plastaras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"II","given":"L.J.","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Rokach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.K.","family":"Shigenaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.B.","family":"Walter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.B.","family":"Tomer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.C.","family":"Barrett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.P.","family":"Mason","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.freeradbiomed.2004.10.024_bib1","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/j.1365-2141.1980.tb05994.x","article-title":"Impaired thromboxane production by newly formed platelets after aspirin administration to thrombocytopenic rats","volume":"46","author":"Dejana","year":"1980","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.freeradbiomed.2004.10.024_bib2","doi-asserted-by":"crossref","first-page":"9383","DOI":"10.1073\/pnas.87.23.9383","article-title":"A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism","volume":"87","author":"Morrow","year":"1990","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.freeradbiomed.2004.10.024_bib3","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.1172\/JCI116143","article-title":"Formation of novel non-cyclooxygenase-derived prostanoids (F2-isoprostanes) in carbon tetrachloride hepatotoxicity: An animal model of lipid peroxidation","volume":"90","author":"Morrow","year":"1992","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.freeradbiomed.2004.10.024_bib4","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/S0022-3565(25)12087-9","article-title":"Immunological characterization of urinary 8-epi-prostaglandin F2\u03b1 excretion in man","volume":"275","author":"Wang","year":"1995","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.freeradbiomed.2004.10.024_bib5","doi-asserted-by":"crossref","first-page":"24441","DOI":"10.1074\/jbc.274.35.24441","article-title":"Isoprostanes: formation, analysis and use as indices of lipid peroxidation in vivo","volume":"274","author":"Lawson","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.freeradbiomed.2004.10.024_bib6","doi-asserted-by":"crossref","first-page":"9800","DOI":"10.1074\/jbc.270.17.9800","article-title":"Cyclooxygenase-dependent formation of the isoprostane, 8-epi-prostaglandin F2\u03b1","volume":"270","author":"Pratico","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.freeradbiomed.2004.10.024_bib7","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1038\/sj.bjp.0701321","article-title":"Reduction of urinary 8-epi-prostaglandin F2\u03b1 during cyclooxygenase inhibition in rats but not in man","volume":"121","author":"Bachi","year":"1997","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.freeradbiomed.2004.10.024_bib8","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1016\/S0022-3565(24)36968-X","article-title":"Generation of the isoprostane 8-epi-prostaglandin F2\u03b1 in vitro and in vivo via the cyclooxygenases","volume":"282","author":"Klein","year":"1997","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.freeradbiomed.2004.10.024_bib9","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1002\/(SICI)1096-9888(199712)32:12<1362::AID-JMS606>3.0.CO;2-N","article-title":"Improved quantification of 8-epi-prostaglandin F2\u03b1 and F2-isoprostanes by gas chromatography\/triple-stage quadripole mass spectrometry: partial cyclooxygenase-dependent formation of 8-epi-prostaglandin F2\u03b1 in humans","volume":"32","author":"Schweer","year":"1997","journal-title":"J. Mass Spectrometry"},{"key":"10.1016\/j.freeradbiomed.2004.10.024_bib10","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1006\/bbrc.1998.9956","article-title":"Oxidative injury induced cyclooxygenase activation in experimental hepatotoxicity","volume":"254","author":"Basu","year":"1999","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.freeradbiomed.2004.10.024_bib11","first-page":"233","article-title":"Physiological formation of 8-epi-PGF2\u03b1 in vivo is not affected by cyclooxygenase inhibition","volume":"23","author":"Catella","year":"1995","journal-title":"Adv. Prostaglandin, Thromboxane, Leucotriene Res."},{"key":"10.1016\/j.freeradbiomed.2004.10.024_bib12","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1081\/DMR-100102340","article-title":"The isoprostanes: their quantification as an index of oxidant stress status in vivo","volume":"32","author":"Morrow","year":"2000","journal-title":"Drug Metab. Rev."},{"key":"10.1016\/j.freeradbiomed.2004.10.024_bib13","doi-asserted-by":"crossref","first-page":"14916","DOI":"10.1074\/jbc.271.25.14916","article-title":"Local amplification of platelet function by 8-epi-prostaglandin F2\u03b1 is not mediated by thromboxane receptor isoforms","volume":"271","author":"Pratico","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.freeradbiomed.2004.10.024_bib14","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1172\/JCI9523","article-title":"Effect of regulated expression of human cyclooxygenase isoforms on eicosanoid and isoeicosanoid production in inflammation","volume":"105","author":"McAdam","year":"2000","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.freeradbiomed.2004.10.024_bib15","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1161\/01.CIR.94.1.19","article-title":"Modulation of oxidant stress in vivo in chronic cigarette smokers","volume":"94","author":"Reilly","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.freeradbiomed.2004.10.024_bib16","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1146\/annurev.pharmtox.38.1.97","article-title":"Cyclooxygenases 1 and 2","volume":"38","author":"Vane","year":"1998","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.freeradbiomed.2004.10.024_bib17","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0223-5234(01)01197-7","article-title":"Cyclooxygenase inhibitors-current status and future prospects","volume":"36","author":"Dannhardt","year":"2001","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.freeradbiomed.2004.10.024_bib18","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0009-2797(02)00052-2","article-title":"Idiosyncratic NSAID drug induced oxidative stress","volume":"142","author":"Galati","year":"2002","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.freeradbiomed.2004.10.024_bib19","first-page":"1025","article-title":"An update on eicosanoids and inhibitors of cyclooxygenase enzyme systems","volume":"35","author":"Sharma","year":"1997","journal-title":"Indian J. Exp. Biol."},{"key":"10.1016\/j.freeradbiomed.2004.10.024_bib20","first-page":"473","article-title":"Prostaglandins and inflammation: the cyclooxygenase controversy","volume":"48","author":"Morteau","year":"2000","journal-title":"Arch. Immunol. Ther. Exp."},{"key":"10.1016\/j.freeradbiomed.2004.10.024_bib21","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S1093-3263(01)00135-8","article-title":"Differential binding mode of diverse cyclooxygenase inhibitors","volume":"20","author":"Llorens","year":"2002","journal-title":"J. Mol. Graph. Model."},{"key":"10.1016\/j.freeradbiomed.2004.10.024_bib22","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1146\/annurev.biochem.69.1.145","article-title":"Cyclooxygenases: structural, cellular, and molecular biology","volume":"69","author":"Smith","year":"2000","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.freeradbiomed.2004.10.024_bib23","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1056\/NEJM200108093450607","article-title":"The coxibs, selective inhibitors of cyclooxygenase-2","volume":"345","author":"FitzGerald","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.freeradbiomed.2004.10.024_bib24","doi-asserted-by":"crossref","first-page":"S78","DOI":"10.1007\/s000110050284","article-title":"Anti-inflammatory drugs and their mechanism of action","volume":"47","author":"Vane","year":"1998","journal-title":"Inflamm. Res."},{"key":"10.1016\/j.freeradbiomed.2004.10.024_bib25","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/0929-7855(95)00015-I","article-title":"Prostaglandin endoperoxide synthase-1 and -2","volume":"12","author":"Otto","year":"1995","journal-title":"J. Lipid Mediat. Cell Signal."},{"key":"10.1016\/j.freeradbiomed.2004.10.024_bib26","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1161\/01.RES.82.9.1016","article-title":"Aspirin increases ferritin synthesis in endothelial cells: a novel antioxidant pathway","volume":"82","author":"Oberle","year":"1998","journal-title":"Circ. Res."},{"key":"10.1016\/j.freeradbiomed.2004.10.024_bib27","doi-asserted-by":"crossref","first-page":"2867","DOI":"10.1096\/fasebj.2.13.2844616","article-title":"Oxidants, inflammation and anti-inflammatory drugs","volume":"2","author":"Halliwell","year":"1988","journal-title":"FASEB J."},{"key":"10.1016\/j.freeradbiomed.2004.10.024_bib28","first-page":"163","article-title":"The mechanism of action of nonsteroidal anti-inflammatory drugs","volume":"7","author":"Abramson","year":"1989","journal-title":"Clin. Exp. Rheum."},{"key":"10.1016\/j.freeradbiomed.2004.10.024_bib29","unstructured":"Kadiiska, M. B.; Gladen, B. C.; Baird, D. B.; Germolec, D.; Graham, L. B.; Parker, C. E.; Nyska, A.; Wachsman, J. T.; Ames, B. N.; Basu, S.; Brot, N.; FitzGerald, G. A.; Floyd, R. A.; George, M.; Heinecke, J. W.; Hatch, G. E.; Hensley, K.; Lawson, J. A.; Marnett, L. J.; Morrow, J. D.; Murray, D. M.; Plastaras, J.; Roberts, L. J.; Rokach, J.; Shigenaga, M. K.; Sohal, R. S.; Sun, J.; Tice, R. R.; Van Thiel, D. H.; Wellner, D.; Walter, P. B.; Tomer, K. B.; Mason, R. P.; Barrett, J. C. Biomarkers of Oxidative Stress Study II: Are oxidation products of lipids, proteins and DNA markers in CCl4 poisoning? Free Radic. Biol. Med.; in press."},{"key":"10.1016\/j.freeradbiomed.2004.10.024_bib30","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0022-3565(25)21417-3","article-title":"Defective modulation of noradrenergic neurotransmission by endogenous prostaglandins in aging spontaneously hypertensive rats","volume":"250","author":"Jackson","year":"1989","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.freeradbiomed.2004.10.024_bib31","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/S0891-5849(00)00198-2","article-title":"Biomarkers of Oxidative Stress Study: Are plasma antioxidants markers of CCl4 poisoning?","volume":"28","author":"Kadiiska","year":"2000","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.freeradbiomed.2004.10.024_bib32","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1006\/abio.1994.1355","article-title":"Assay of malondialdehyde in biological fluids by gas chromatography-mass spectrometry","volume":"220","author":"Yeo","year":"1994","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.freeradbiomed.2004.10.024_bib33","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0076-6879(99)00106-8","article-title":"Mass spectrophotometric quantification of F2-isoprostanes in biological fluids and tissues as measure of oxidant stress","volume":"300","author":"Morrow","year":"1999","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.freeradbiomed.2004.10.024_bib34","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1385\/MB:18:2:105","article-title":"An improved GC\/MS-based procedure for quantitation of the isoprostane 15-F2t-IsoP in rat plasma","volume":"18","author":"Parker","year":"2001","journal-title":"Mol. Biotechnol."},{"key":"10.1016\/j.freeradbiomed.2004.10.024_bib35","doi-asserted-by":"crossref","first-page":"13381","DOI":"10.1073\/pnas.96.23.13381","article-title":"Quantitative high performance liquid chromatography\/tandem mass spectrometric analysis of the four classes of F2-isoprostanes in human urine","volume":"96","author":"Li","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.freeradbiomed.2004.10.024_bib36","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0952-3278(98)90042-4","article-title":"Radioimmunoassay of 8-iso-prostaglandin-F2\u03b1: an index for oxidative injury via free radical catalyzed lipid peroxidation","volume":"58","author":"Basu","year":"1998","journal-title":"Prostaglandins, Leukot. Essent. Fatty Acids"},{"key":"10.1016\/j.freeradbiomed.2004.10.024_bib37","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s000110050494","article-title":"Cyclooxygenase-2-dependent generation of 8-epi-prostaglandin F2\u03b1 by lipopolysaccharide-activated J774 macrophages","volume":"48","author":"Sautebin","year":"1999","journal-title":"Inflamm. Res."},{"key":"10.1016\/j.freeradbiomed.2004.10.024_bib38","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1042\/bj3440747","article-title":"Synthesis of 8-epi-prostaglandin F2\u03b1 by human endothelial cells: role of prostaglandin H2 synthase","volume":"344","author":"Watkins","year":"1999","journal-title":"Biochem. J."},{"key":"10.1016\/j.freeradbiomed.2004.10.024_bib39","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/0006-2952(87)90175-4","article-title":"Preparative HPLC purification of prostaglandin endoperoxides and isolation of novel cyclooxygenase-derived arachidonic acid metabolites","volume":"36","author":"Hecker","year":"1987","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.freeradbiomed.2004.10.024_bib40","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1073\/pnas.97.2.925","article-title":"Biochemically based design of cyclooxygenase-2 (COX-2) inhibitors: facile conversion of nonsteroidal anti-inflammatory drugs to potent and highly selective COX-2 inhibitors","volume":"97","author":"Kalgutkar","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.freeradbiomed.2004.10.024_bib41","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1074\/jbc.274.2.762","article-title":"Expression, purification, and spectroscopic characterization of human thromboxane synthase","volume":"274","author":"Hsu","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.freeradbiomed.2004.10.024_bib42","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1002\/(SICI)1521-4184(199811)331:11<359::AID-ARDP359>3.0.CO;2-B","article-title":"Spectrofluorimetric quantification of malondialdehyde for evaluation of cyclooxygenase-1\/thromboxane synthase inhibition","volume":"331","author":"Dannhardt","year":"1998","journal-title":"Archiv. Pharm."},{"key":"10.1016\/j.freeradbiomed.2004.10.024_bib43","doi-asserted-by":"crossref","first-page":"3449","DOI":"10.1073\/pnas.95.7.3449","article-title":"IPF2\u03b1-I: an index of lipid peroxidation in humans","volume":"95","author":"Pratico","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"}],"container-title":["Free Radical Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891584904008470?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891584904008470?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T15:57:38Z","timestamp":1760198258000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0891584904008470"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,3]]},"references-count":43,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2005,3]]}},"alternative-id":["S0891584904008470"],"URL":"https:\/\/doi.org\/10.1016\/j.freeradbiomed.2004.10.024","relation":{},"ISSN":["0891-5849"],"issn-type":[{"value":"0891-5849","type":"print"}],"subject":[],"published":{"date-parts":[[2005,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Biomarkers of oxidative stress study","name":"articletitle","label":"Article Title"},{"value":"Free Radical Biology and Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.freeradbiomed.2004.10.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}